HABA Laboratories,Inc. (TYO:4925)
Japan · Delayed Price · Currency is JPY 1,760.00
+8.00 (0.46%)
Jul 31, 2026, 2:10 PM JST
HABA Laboratories,Inc. Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 12,141 | 12,141 | 12,061 | 12,324 | 12,038 | 12,908 |
Revenue Growth | 0.66% | 0.66% | -2.13% | 2.38% | -6.74% | -9.78% |
Gross Profit Gross Profit Growth | 8,087 | 8,087 | 8,092 | 8,404 | 8,169 | 8,794 |
Operating Income Operating Income Growth | 713 | 713 | 589 | -187 | -609 | -317 |
Net Income Net Income Growth | 760 | 760 | 576 | -2,118 | -707 | -269 |
Earnings Per Share EPS Growth | 200.98 | 200.98 | 152.32 | -560.09 | -186.96 | -71.13 |
EPS Growth | 31.95% | 31.95% | - | - | - | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 5,784 | 5,784 | 4,743 | 3,959 | 4,817 | 5,651 |
Total Debt Total Debt Growth | 1,187 | 1,187 | 1,816 | 2,354 | 2,032 | 2,557 |
Net Cash (Debt) Net Cash Growth | 4,597 | 4,597 | 2,927 | 1,605 | 2,785 | 3,094 |
Net Cash Growth | 57.05% | 57.05% | 82.37% | -42.37% | -9.99% | 77.31% |
Net Cash Per Share Net Cash Per Share Growth | 1215.66 | 1215.66 | 774.03 | 424.43 | 736.48 | 818.18 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,237 | 1,237 | 1,621 | -587 | 55 | 1,714 |
Capital Expenditures CapEx Growth | -77 | -77 | -138 | -154 | -191 | -124 |
Free Cash Flow Free Cash Flow Growth | 1,160 | 1,160 | 1,483 | -741 | -136 | 1,590 |
Free Cash Flow Growth | -21.78% | -21.78% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 66.61% | 66.61% | 67.09% | 68.19% | 67.86% | 68.13% |
Operating Margin | 5.87% | 5.87% | 4.88% | -1.52% | -5.06% | -2.46% |
Pretax Margin | 6.99% | 6.99% | 5.26% | -14.95% | -4.55% | -2.07% |
Profit Margin | 6.26% | 6.26% | 4.78% | -17.19% | -5.87% | -2.08% |
FCF Margin | 9.55% | 9.55% | 12.30% | -6.01% | -1.13% | 12.32% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 40.000 | 40.000 | 40.000 | 40.000 | 40.000 | 40.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 2.28% | 2.35% | 2.35% | 2.01% | 1.83% | 2.00% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.76 | 8.46 | 11.42 | - | - | - |
P/FCF Ratio | 5.74 | 5.55 | 4.44 | - | - | 5.14 |
PS Ratio | 0.55 | 0.53 | 0.55 | 0.64 | 0.73 | 0.63 |